INIS
patients
94%
glucose
62%
diseases
58%
risks
58%
people
46%
insulin
40%
levels
40%
adults
37%
data
36%
comparative evaluations
35%
populations
29%
reviews
29%
metabolism
28%
diabetes mellitus
28%
control
26%
liver
23%
quality of life
20%
sex
20%
plasma
19%
men
19%
management
18%
sensitivity
17%
symptoms
17%
women
17%
lipids
16%
ulcers
16%
guidelines
15%
arteries
14%
brain
13%
design
13%
inflammation
13%
interventions
13%
thyroid
13%
biological markers
13%
cardiovascular diseases
12%
performance
12%
muscles
12%
humans
11%
tumors
11%
carcinomas
11%
intake
10%
range
10%
monitoring
10%
fructose
10%
proteins
10%
concentration
10%
tolerance
10%
genes
10%
therapy
9%
stiffness
9%
skin
9%
assessments
9%
adjustments
9%
blood
9%
kidneys
9%
values
9%
hormones
9%
genetics
9%
obesity
8%
cholesterol
8%
regression analysis
8%
receptors
8%
blood pressure
8%
fats
8%
pancreas
7%
healing
7%
fasting
7%
cancer
7%
prediction
7%
education
7%
incidents
7%
nerves
7%
mortality
7%
thickness
7%
recommendations
7%
volume
7%
metabolites
6%
adipose tissue
6%
peptides
6%
losses
6%
diet
6%
triglycerides
6%
sensors
6%
hazards
6%
children
6%
netherlands
6%
oxidation
5%
evaluation
5%
screening
5%
validation
5%
energy
5%
surgery
5%
clinical trials
5%
density
5%
exercise
5%
sleep
5%
adolescents
5%
velocity
5%
fibers
5%
pulses
5%
Keyphrases
Maastricht
100%
Type 2 Diabetes Mellitus (T2DM)
85%
Hypoglycemia
30%
Type 1 Diabetes Mellitus (T1DM)
30%
Diabetes
25%
Type I Diabetes
22%
Pre-diabetes (pre-DM)
21%
Patients with Diabetes
19%
Diabetic Foot
18%
Dutch
14%
Type 2 Diabetic Patients
13%
Insulin Sensitivity
13%
Peripheral Arterial Disease
13%
Confidence Interval
13%
Multiple Endocrine Neoplasia Type 1 (MEN1)
13%
International Working Groups
12%
Hemoglobin A1c (HbA1c)
12%
Quality of Life
11%
Physical Activity
10%
Normal Glucose Tolerance
10%
Non-alcoholic Fatty Liver Disease (NAFLD)
9%
Hepatic Fat
9%
Cardiovascular Disease
9%
Diabetic Foot Ulcer
9%
Depressive Symptoms
8%
Population-based Cohort Study
8%
Foot Ulcer
8%
Insulin
8%
Arterial Stiffness
8%
Cardiovascular Risk
8%
Randomized Controlled Trial
8%
Glycemic Control
7%
Fructose
7%
Skeletal muscle
7%
Continuous Glucose Monitoring
7%
Insulin Resistance
7%
Hypoglycemia Unawareness
6%
Non-associated
6%
Netherlands
6%
Sedentary Behavior
6%
Without Diabetes
6%
Risk Factors
6%
Hypo
6%
Cognitive Performance
6%
Odds Ratio
6%
Advanced Glycation End Products
6%
Oral Glucose Tolerance Test
5%
Glucose Metabolism Status
5%
Glucose Variability
5%
Health-related Quality of Life
5%
Microvascular Dysfunction
5%
Endothelial Dysfunction
5%
Placebo
5%
Healthcare Professionals
5%
Sex Hormone-binding Globulin
5%
Body Mass Index
5%
Hyperglycemia
5%
Survivors
5%
Metformin
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
62%
Diabetes
41%
Impaired Glucose Tolerance
20%
Hypoglycemia
19%
Systematic Review
17%
Insulin Dependent Diabetes Mellitus
15%
Glucose Metabolism
13%
Quality of Life
13%
Arteriosclerosis Obliterans
13%
Physical Activity
12%
Multiple Endocrine Neoplasia Type I
12%
Cardiovascular Disease
11%
Diabetes Mellitus
11%
Biological Marker
11%
Arterial Stiffness
10%
Cohort Analysis
8%
Depressive Disorder
8%
Diseases
8%
Foot Ulcer
7%
Differentiated Thyroid Cancer
7%
Insulin Sensitivity
7%
Prevalence
6%
Awareness
6%
Endothelial Dysfunction
6%
Foot Disease
6%
Cardiovascular System
6%
Body Mass Index
6%
Diabetic Neuropathy
6%
Glycemic Control
5%
Nonalcoholic Fatty Liver
5%
Hemoglobin A1c
5%
Diabetic Foot Ulcer
5%
Patient with Type 2 Diabetes
5%
Randomized Controlled Trial
5%
Pulse Wave Velocity
5%
Skeletal Muscle
5%
Oral Glucose Tolerance Test
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%